0000929638-25-001517.txt : 20250408 0000929638-25-001517.hdr.sgml : 20250408 20250407201250 ACCESSION NUMBER: 0000929638-25-001517 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20250408 DATE AS OF CHANGE: 20250407 EFFECTIVENESS DATE: 20250408 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NEUTROLIS INC. CENTRAL INDEX KEY: 0001788926 ORGANIZATION NAME: EIN: 822144641 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-543136 FILM NUMBER: 25819772 BUSINESS ADDRESS: STREET 1: 1 BROADWAY, FLOOR 14 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 857-930-3397 MAIL ADDRESS: STREET 1: 1 BROADWAY, FLOOR 14 CITY: CAMBRIDGE STATE: MA ZIP: 02142 D 1 primary_doc.xml X0708 D LIVE 0001788926 NEUTROLIS INC. 1 BROADWAY, FLOOR 14 CAMBRIDGE MA MASSACHUSETTS 02142 857-930-3397 DELAWARE Neutrolis Therapeutics, Inc. None Corporation true Abdul Hakkim Rahamathullah 1 Broadway, Floor 14 Cambridge MA MASSACHUSETTS 02142 Director Executive Officer Promoter Mr. Rahamathullah is also the Co-Founder, Co-President and Treasurer of the Issuer. Toby Fox 1 Broadway, Floor 14 Cambridge MA MASSACHUSETTS 02142 Director Executive Officer Promoter Mr. Fox is also the Co-Founder, Chief Executive Officer, Co-President and Secretary of the Issuer. Gerald Chan 1 Broadway, Floor 14 Cambridge MA MASSACHUSETTS 02142 Director Anthony Aiudi 1 Broadway, Floor 14 Cambridge MA MASSACHUSETTS 02142 Director John Sundy 1 Broadway, Floor 14 Cambridge MA MASSACHUSETTS 02142 Director Biotechnology Decline to Disclose 06b false 2025-02-28 false true true Common and Series A-4 Preferred Stock false 0 1000000 964955 35045 false 9 0 0 0 false NEUTROLIS INC. /s/ Toby Fox Toby Fox Chief Executive Officer of the Issuer 2025-04-07